ArticleBioengineered2021

Early 2 factor (E2F) transcription factors contribute to malignant progression and have clinical prognostic value in lower-grade glioma.

Haitao Luo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.